Skip to content
The Yangtzeer

The Yangtzeer

Covering the people, capital and innovation shaping the Yangtze River Delta

  • Home
  • News
    • Deals
    • Heavy Hitters
    • Startups
    • Policy
    • Research
  • Feature
    • Industry Pulse
    • Unicorn Club
    • Cluster Spotlight
    • Policy Decoded
  • Opinion
    • Editor’s View
    • Guest Posts
  • People
    • Old Guard
    • New Wave
    • Capital Journal
  • About
  • Contact
  • Privacy Policy
  • Home
  • AIDD

Tag: AIDD

  • News
  • Research

Westlake University’s AI-designed drug wins first approval in China

Yangtzeer observers2026-09-032026-09-0304 mins

The drug took about three and a half years to reach approval, far shorter than the traditional drug-development timeline.

Read More

Recent News

  • Today’s Yangtze funding roundup: CNS drug, flying robot, eVTOL…
  • Leapmotor’s million-car race is a sprint it cannot afford to lose
  • Hangzhou gives young entrepreneurs a break on their AI bills
  • Shanghai summit to put AI to work as robots move from demos to real jobs
  • Pudong wins national pilot to tackle embodied AI’s data shortage

Archives

  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
« Aug    
Copyright © 2026 The Yangtzeer. All rights reserved. Powered By BlazeThemes.